Malignant News and Research

RSS

AngioGenex files patent on first small molecule Id-inhibitors

AngioGenex Inc. has identified and filed a patent application on small molecules that are potent inhibitors of the Id proteins.

17 Oct 2007

A tumor marker Ca 19-9 in diabetics can lead to misdiagnosis of pancreatic cancer

Diabetes is increasing all over the world along with the increase of obesity and associated diseases and is a well-known risk factor for pancreatic cancer. The incidence of pancreatic cancer is also increasing and has one of the lowest survival rates of all cancers.

16 Oct 2007

Delisheng shows anti-cancer effects on hepatocellular carcinoma

Traditional Chinese medicine is world renowned. It has supernatural effects on some diseases, but the reason is still unknown. One such article was recently reported in the November 7 issue of the World Journal of Gastroenterology dealing with the great significance of a Chinese medicinal compound, "delisheng", for the therapy of HCC and its neoteric research method.

16 Oct 2007

New near-infrared contrast agent reveals bone and breast-cancer-related microcalcifications

Mammography continues to be the method of choice for the early detection of breast cancer. However, because this technique is not as selective or specific as one would wish, and does not deliver reliable results for every level of tissue density, alternatives are being sought.

15 Oct 2007

Bacteria reveal targets of immune responses quick and direct identification of antigens

The Epstein-Barr virus (EBV) is a widespread herpes virus that infects more than 90 per cent of the worldwide human population.

10 Oct 2007

18F-DG PET/CT can highly increase the detection of colorectal cancer

Combined positron emission tomography and computed tomography (PET/CT) is currently widely used in the clinical diagnosis of cancer to provide functional and morphological imaging.

10 Oct 2007

M-POSSUM evaluation system improves accuracy and effectiveness of the original system

Based on POSSUM, a system suggested by some British scholars more than 10 years ago, a team led by Dr. Lian-An Ding has established the M-POSSUM evaluation system with the aim of improving the accuracy and effectiveness of the original system.

10 Oct 2007

Interleukin-8, key marker for colorectal cancer treatment

Colorectal cancer (CRC) is currently one of the three most frequent malignancies in Western industrial nations.

10 Oct 2007

Additional biopsy-scoring data may help determine prostate cancer prognosis

Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the October 3 issue of JAMA.

3 Oct 2007

Over 60's do well after liver transplantation

Patients who undergo liver transplantation at age 60 or above have 1-year and 5-year survival rates similar to those of younger patients and they experience fewer episodes of rejection.

3 Oct 2007

Fetal cell transplant could be a hidden link between childbirth and reduced risk of breast cancer

Some benefits of motherhood are intangible, but one has been validated through biostatistical research: women who bear children have a reduced risk of developing breast cancer.

3 Oct 2007

Fetal cell "transplant" could be a hidden link between childbirth and reduced risk of breast cancer

Some benefits of motherhood are intangible, but one has been validated through biostatistical research: women who bear children have a reduced risk of developing breast cancer.

2 Oct 2007

Daisy compound used to attack cancer stem cells

A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.

2 Oct 2007

Residual fetal cells in women may provide protection against breast cancer

Fetal cells that persist in a woman's body long after pregnancy - a common occurrence known in scientific circles as fetal microchimerism - in some cases may reduce the woman's risk of breast cancer, according to researchers at Fred Hutchinson Cancer Research Center.

2 Oct 2007

Residual fetal cells in women both detrimental and beneficial to women's health

Fetal cells that persist in a woman's body long after pregnancy – a common occurrence known in scientific circles as fetal microchimerism – in some cases may reduce the woman's risk of breast cancer, according to researchers at Fred Hutchinson Cancer Research Center.

1 Oct 2007

Malignant News and Research

AngioGenex files patent on first small molecule Id-inhibitors

A tumor marker Ca 19-9 in diabetics can lead to misdiagnosis of pancreatic cancer

Delisheng shows anti-cancer effects on hepatocellular carcinoma

New near-infrared contrast agent reveals bone and breast-cancer-related microcalcifications

Bacteria reveal targets of immune responses quick and direct identification of antigens

18F-DG PET/CT can highly increase the detection of colorectal cancer

M-POSSUM evaluation system improves accuracy and effectiveness of the original system

Interleukin-8, key marker for colorectal cancer treatment

Additional biopsy-scoring data may help determine prostate cancer prognosis

Over 60's do well after liver transplantation

Fetal cell transplant could be a hidden link between childbirth and reduced risk of breast cancer

Fetal cell "transplant" could be a hidden link between childbirth and reduced risk of breast cancer

Daisy compound used to attack cancer stem cells

Residual fetal cells in women may provide protection against breast cancer

Residual fetal cells in women both detrimental and beneficial to women's health

Researchers discover one of the mechanisms that prevents the spread of colon cancer

Pregnancy does not harm chances of survival from cancer

DNA damage response confers a barrier for viral tumorigenesis

Diet and medications may assist prevention of prostate cancer

Heat shock proteins are co-opted for cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News